Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
27.77
0.15 (0.54%)
At close: Aug 15, 2025, 3:59 PM
27.61
-0.55%
After-hours: Aug 15, 2025, 07:52 PM EDT
Apellis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 754.65M | 775.84M | 781.37M | 715.22M | 628.79M | 524.07M | 396.59M | 272.88M | 184.53M | 105.89M | 75.42M | 113.05M | 96.64M | 80.94M | 66.56M | 256.27M | 251.27M | 250.65M |
Cost of Revenue | 122.84M | 132.32M | 118.61M | 97.67M | 86.52M | 71.35M | 58.51M | 41.52M | 20.49M | 12.2M | 5.63M | 7.76M | 6.53M | 56.45M | 179.79M | 228.75M | 321.8M | 387.31M |
Gross Profit | 631.8M | 643.52M | 662.75M | 617.55M | 542.26M | 357.06M | 242.42M | 135.7M | 68.38M | 93.69M | 69.79M | 105.29M | 89.78M | 24.16M | -113.56M | 27.19M | -70.53M | -136.67M |
Operating Income | -190.06M | -186.22M | -164.98M | -223.33M | -324.35M | -415.35M | -528.34M | -607.87M | -612.51M | -640.7M | -594.61M | -519.96M | -495.02M | -540.68M | -536.28M | -316.75M | -318.31M | -239.53M |
Interest Income | 11.55M | 12.13M | 12.77M | 13.92M | 16.02M | 18.84M | 20.93M | 20.96M | 18.78M | 14.21M | 8.91M | 4.38M | 1.71M | 383K | 419K | 576K | 1.1M | 2.02M |
Pretax Income | -226.49M | -222.35M | -196.72M | -247.8M | -330.95M | -415.25M | -526.5M | -606.8M | -657.62M | -691.27M | -651.5M | -631.62M | -636.37M | -700.07M | -746M | -518.31M | -458.44M | -357.87M |
Net Income | -228.17M | -223.68M | -197.88M | -250.1M | -332.89M | -417.27M | -528.63M | -606.04M | -657.08M | -691.01M | -652.17M | -634.11M | -638.42M | -701.63M | -746.35M | -520.16M | -460.29M | -359.71M |
Selling & General & Admin | 503.5M | 500.44M | 500.16M | 520.38M | 544.04M | 527.78M | 500.81M | 443.48M | 376.24M | 328.07M | 277.16M | 234.26M | 201.62M | 187.38M | 176.77M | 179.8M | 171.03M | 150.48M |
Research & Development | 318.36M | 329.29M | 327.57M | 320.5M | 311.35M | 329.06M | 354.39M | 384.53M | 400.31M | 406.32M | 387.24M | 395.99M | 388.52M | 432.8M | 425.87M | 368.02M | 373.5M | 314.65M |
Other Expenses | n/a | 24K | -475K | -256K | -859K | -946K | -724K | -1.19M | -487K | -275K | -287K | -45K | -261K | -471K | 1.36M | 861K | 962K | 1.03M |
Operating Expenses | 821.86M | 829.73M | 827.73M | 840.88M | 855.39M | 856.85M | 855.2M | 828.01M | 776.55M | 734.39M | 664.4M | 625.25M | 585.13M | 565.18M | 547.64M | 522.88M | 426.37M | 396.97M |
Interest Expense | 46.27M | 44.47M | 40.39M | 36.26M | 31.04M | 29.02M | 29.58M | 29.92M | 30.51M | 31.62M | 32.63M | 27.91M | 22.29M | 17.61M | 13.24M | 19.83M | 27.05M | 30.19M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 944.71M | 962.05M | 946.35M | 938.55M | 941.92M | 928.2M | 913.71M | 869.53M | 797.05M | 746.59M | 670.03M | 633.01M | 591.66M | 621.63M | 602.84M | 573.02M | 569.58M | 490.18M |
Income Tax Expense | 1.69M | 1.33M | 1.16M | 2.3M | 1.94M | 2.02M | 2.13M | -762K | -549K | -257K | 669K | 2.49M | 2.05M | 1.56M | 352K | 1.84K | 1.84K | 1.84K |
Shares Outstanding (Basic) | 126.02M | 125.45M | 123.9M | 123.9M | 123.9M | 122.96M | 121.23M | 120.29M | 119.32M | 113.87M | 110.63M | 109.13M | 106.63M | 97.84M | 85.66M | 85.66M | 80.65M | 79.22M |
Shares Outstanding (Diluted) | 126.02M | 125.45M | 123.9M | 123.9M | 123.9M | 122.96M | 121.23M | 120.29M | 119.32M | 113.87M | 110.63M | 109.13M | 106.63M | 98.07M | 85.66M | 85.66M | 80.65M | 79.22M |
EPS (Basic) | -1.82 | -1.79 | -1.59 | -2.03 | -2.74 | -3.46 | -4.48 | -5.25 | -5.83 | -6.27 | -6.13 | -6.36 | -6.89 | -8.15 | -9.05 | -6.33 | -5.84 | -4.69 |
EPS (Diluted) | -1.82 | -1.79 | -1.59 | -2.03 | -2.74 | -3.46 | -4.48 | -5.25 | -5.83 | -6.27 | -6.13 | -6.36 | -6.89 | -8.15 | -9.05 | -6.33 | -5.84 | -4.69 |
EBITDA | -178.43M | -176.07M | -154.53M | -209.7M | -298.13M | -384.48M | -495.21M | -575.25M | -625.52M | -658.13M | -617.39M | -602.28M | -612.73M | -681.01M | -731.27M | -497.08M | -429.95M | -326.56M |
EBIT | -180.22M | -177.87M | -156.32M | -211.54M | -299.92M | -386.23M | -496.91M | -576.89M | -627.11M | -659.65M | -618.88M | -603.87M | -614.24M | -682.62M | -732.92M | -498.48M | -431.39M | -327.67M |
Depreciation & Amortization | 1.8M | 1.8M | 1.8M | 1.84M | 1.79M | 1.75M | 1.7M | 1.64M | 1.59M | 1.53M | 1.49M | 1.44M | 1.35M | 1.46M | 1.49M | 537K | 578K | 252K |